Study of a heart valve implant after 30 days
Part of Heart & circulation clinical trials.
This study looks at people who already received the Myval THV heart valve implant for severe native aortic valve narrowing. It checks how patients are doing after at least 30 days of follow-up to better understand the valve’s performance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received the Myval THV series valve implant in your aortic valve
- Your valve problem must have been severe aortic stenosis (aortic valve narrowing)
- Your valve implant must be for your natural (native) aortic valve
- You must have completed at least 30 days of follow-up after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This study looks at how well a new valve (Myval) works when placed inside a previous TAVI valve that has stopped working properly. It may help people who need another valve replacement without open-heart surgery.
This trial studies whether the Myval THV (a new heart valve) is safe and effective for adults who need TAVI, a procedure to replace a narrowed heart valve without open-heart surgery. You may be considered if a heart team says you’re a good candidate for this valve procedure and you’re willing to join the study.
This registry tracks people getting a new heart valve called Myval. It's designed to see how well it works in real-world care.
This study collects information on people who have already received a new aortic valve through a small cut in their armpit using the Myval valve. Doctors want to see how well this approach works over time.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.